Evidence map›Paper›PMID 26474064›Full record

ArticleMolecular cell2015

Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.

Emma E Vincent, Alexey Sergushichev, Takla Griss, Marie-Claude Gingras, Bozena Samborska, Thierry Ntimbane, Paula P Coelho, Julianna Blagih, Thomas C Raissi, Luc Choinière and 10 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 1 synthesis or guideline pooled it, 290 citations in OpenAlex.

  1. Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer.Frontiers in cell and developmental biology · 2021
    Pooled it
  2. The mitochondrial chaperone HSPD1 folds MTHFD2 independently of its co-chaperone HSPE1.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Article
  3. Article
  4. Histone deacetylases in cancer metabolic reprogramming.Experimental & molecular medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mitochondrial control of glycerolipid synthesis by a PEP shuttle.bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Timing of Glucocorticoid Treatment Dictates Glucocorticoid Receptor Actions Modulating the NLRP3-Inflammasome Activation in Macrophages.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Emma E VincentGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Alexey SergushichevITMO University, Saint Petersburg 197101, Russia; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA.
Takla GrissGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Marie-Claude GingrasGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.
Bozena SamborskaGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Thierry NtimbaneGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Metabolomics Core Facility, Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.
Paula P CoelhoGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Julianna BlagihGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Thomas C RaissiGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Luc ChoinièreGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Metabolomics Core Facility, Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.
Gaëlle BridonGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Metabolomics Core Facility, Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.
Ekaterina LoginichevaDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA.
Breanna R FlynnGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada.
Elaine C ThomasSchool of Biochemistry, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, UK.
Jeremy M TavaréSchool of Biochemistry, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, UK.
Daina AvizonisGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Metabolomics Core Facility, Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada.
Arnim PauseGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.
Douglas J E ElderSchool of Biochemistry, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, UK.
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA. Electronic address: martyomov@pathology.wustl.edu.
Russell G JonesGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, Canada; Department of Physiology, McGill University, Montreal, QC H3G 1Y6, Canada. Electronic address: russell.jones@mcgill.ca.
McGill University · CAMcGill University Health Centre · CAUniversity of Bristol · GBWashington University in St. Louis · USITMO University · RU

Funding

Cancer Research UK 14402CIHR MOP-93799
6 · The paper itself

Abstract

Cancer cells adapt metabolically to proliferate under nutrient limitation. Here we used combined transcriptional-metabolomic network analysis to identify metabolic pathways that support glucose-independent tumor cell proliferation. We found that glucose deprivation stimulated re-wiring of the tricarboxylic acid (TCA) cycle and early steps of gluconeogenesis to promote glucose-independent cell proliferation. Glucose limitation promoted the production of phosphoenolpyruvate (PEP) from glutamine via the activity of mitochondrial PEP-carboxykinase (PCK2). Under these conditions, glutamine-derived PEP was used to fuel biosynthetic pathways normally sustained by glucose, including serine and purine biosynthesis. PCK2 expression was required to maintain tumor cell proliferation under limited-glucose conditions in vitro and tumor growth in vivo. Elevated PCK2 expression is observed in several human tumor types and enriched in tumor tissue from non-small-cell lung cancer (NSCLC) patients. Our results define a role for PCK2 in cancer cell metabolic reprogramming that promotes glucose-independent cell growth and metabolic stress resistance in human tumors.

Indexed as

Gene Expression Regulation, NeoplasticAdaptation, PhysiologicalAnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorCell ProliferationCitric Acid CycleGluconeogenesisGlucoseGlutamineHumansLung NeoplasmsMetabolomicsMiceMice, NudeMitochondriaGlucoseGlutaminePCK2 protein, humanPhosphoenolpyruvatePhosphoenolpyruvate Carboxykinase (ATP)PurinesPyruvic AcidSerine

Identifiers

PMID26474064
OpenAlexW2106318552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.